Effect of initial treatment on disease outcome for patients with submandibular gland carcinoma

Archives of Otolaryngology - Head and Neck Surgery

Volumn 133, Issue 6, 2007, Pages 546-550

  Kaszuba, Scott M ^a   Zafereo, Mark E ^a   Rosenthal, David I ^a   El Naggar, Adel K ^a   Weber, Randal S ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CANCER THERAPY; COMPARATIVE STUDY; DISEASE CONTROL; ENUCLEATION; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; INSTITUTIONAL CARE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATHOLOGY; RADIOGRAPHY; RECURRENT DISEASE; RETROSPECTIVE STUDY; SALIVARY GLAND TUMOR; TERTIARY HEALTH CARE; THERAPY EFFECT; TUMOR BIOPSY;

BIOPSY, FINE-NEEDLE; CARCINOMA; CARCINOMA, ADENOID CYSTIC; CARCINOMA, MUCOEPIDERMOID; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASM, RESIDUAL; RETROSPECTIVE STUDIES; SUBMANDIBULAR GLAND NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 34250844332     PISSN: 08864470     EISSN: 08864470     Source Type: Journal    
DOI: 10.1001/archotol.133.6.546     Document Type: Article

References (27)

1. Pinkston JA, Cole P. Incidence rates of salivary gland tumors: results from a population-based study. Otolaryngol Head Neck Surg. 1999;120:834-840.
2. Cohen AN, Damrose EJ, Huang RY, Nelson SD, Blackwell KE, Calcaterra TC. Adenoid cystic carcinoma of the submandibular gland: a 35-year review. Otolaryngol Head Neck Surg. 2004;131:994-1000.
3. Speight PM, Barrett AW. Salivary gland tumors. Oral Dis. 2002;8:229-240.
4. Armstrong JG, Harrison LB, Spiro RH, Fass DE, Strong EW, Fuks ZY. Malignant tumors of major salivary gland origin. Arch Otolaryngol Head Neck Surg. 1990;116:290-293.
5. Bhattacharyya N. Survival and prognosis for cancer of the submandibular gland. J Oral Maxillofac Surg. 2004;62:427-430.
6. Kaneda T, Minami M, Ozawa K, et al. MR of the submandibular gland: normal and pathologic states. AJNR Am J Neuroradiol. 1996;17:1575-1581.
7. Camilleri IG, Malata CM, McLean NR, Kelly CG. Malignant tumors of the submandibular gland: a 15-year review. Br J Plast Surg. 1998;51:181-185.
8. Byers RM, Jesse RH, Guillamondegui OM, Luna MA. Malignant tumors of the submaxillary gland. Am J Surg. 1973;126:458-463.
9. Weber RS, Byers RM, Petit B, Wolf P, Ang K, Luna M. Submandibular gland tumors. Arch Otolaryngol Head Neck Surg. 1990;116:1055-1060.
10. Conley J, Myers E, Cole R. Analysis of 115 patients with tumors of the submandibular gland. Ann Otol Rhinol Laryngol. 1972;81:323-330.
11. Spiro RH. Salivary neoplasms: overview of a 35-year experience with 2,807 patients. Head Neck Surg. 1986;8:177-184.
12. Wahlberg P, Anderson H, Biorklund A, Moller T, Perfekt R. Carcinoma of the parotid and submandibular glands: a study of survival in 2465 patients. Oral Oncol. 2002;38:706-713.
13. Vander Poorten VL, Balm AJ, Hilgers FJ, et al. Prognostic factors for long-term results of the treatment of patients with malignant submandibular gland tumors. Cancer. 1999;85:2255-2264.
14. Batsakis JG. Tumors of the Head and Neck. Baltimore, Md: Williams & Wilkins Co; 1979:1-75.
15. Greene FL, Page DL, Fleming ID, et al. AJCC Cancer Staging Manual. 6th ed. New York, NY: Springer-Verlag; 2002.
16. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
17. Peto R, Peto J. Asymptotically efficient rank invariant procedures. J R Stat Soc A. 1972;135:185-206.
18. Spiro RH, Armstrong J, Harrison L, Geller NL, Lin SY, Strong EW. Carcinoma of major salivary glands: recent trends. Arch Otolaryngol Head Neck Surg. 1989;115:316-321.
19. Yasumoto M, Shibuya H, Suzuki S, et al. Computed tomography and ultrasonography in submandibular gland tumors. Clin Radiol. 1992;46:114-120.
20. Rapidis AD, Stavrianos S, Lagogiannis G, Faratzis G. Tumors of the submandibular gland: clinicopathologic analysis of 23 patients. J Oral Maxillofac Surg. 2004;62:1203-1208.
21. Li N, Zhu W, Zuo S, Jia M, Sun J. Value of gallium-67 scanning in differentiation of malignant tumors from benign tumors or inflammatory disease in the oral and maxillofacial region. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003;96:361-367.
22. Armstrong JG, Harrison LB, Thaler HT, et al. The indications for elective treatment of the neck in cancer of the major salivary glands. Cancer. 1992;69:615-619.
23. Kokemueller H, Brueggemann N, Swennen G, Eckardt A. Mucoepidermoid carcinoma of the salivary glands: clinical review of 42 cases. Oral Oncol. 2005;41:3-10.
24. Matsuba HM, Thawley SE, Simpson JR, Levine LA, Mauney M. Adenoid cystic carcinoma of major and minor salivary gland origin. Laryngoscope. 1984;94:1316-1318.
25. Storey MR, Garden AS, Morrison WH, Eicher SA, Schechter NR, Ang KK. Postoperative radiotherapy for malignant tumors of the submandibular gland. Int J Radiat Oncol Biol Phys. 2001;51:952-958.
26. Sykes AJ, Slevin NJ, Birzgalis AR, Gupta NK. Submandibular gland carcinoma: an audit of local control and survival following adjuvant radiotherapy. Oral Oncol. 1999;35:187-190.
27. Garden AS, Weber RS, Morrison WH, Ang KK, Peters LJ. The influence of positive margins and nerve invasion in adenoid cystic carcinoma of the head and neck treated with surgery and radiation. Int J Radiat Oncol Biol Phys. 1995;32:619-626.